Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease

Abstract

ABSTRACT. Since 2006, China has conducted the surveillance program for Creutzfeldt-Jakob disease (CJD) and other subtypes of prion diseases covering 12 provinces. In this study, the characteristics and special role of Beijing CJD surveillance network in the national CJD surveillance system were analyzed. Based on the registered permanent resident places, all reporting suspected CJD cases and diagnosed CJD cases via Beijing CJD surveillance network between 2006 and 2013 were grouped as the cases from Beijing and from outside of Beijing. Both numbers of the suspected and diagnosed CJD cases via Beijing CJD surveillance network constantly increased along with the years, totally 532 reporting cases and 192 diagnosed CJD cases were obtained in the past 8 y. About 75% of suspected and diagnosed CJD cases via Beijing CJD surveillance network came from other provinces, mainly from neighboring provinces. Altogether, 46 different hospitals in the Beijing region have reported suspected CJD cases to the CJD surveillance system during the period from 2006 to 2013. Five hospitals continually reported suspected CJD cases during those 8 y and 5 other hospitals had reported cases except for 1 to 2 y. Additionally, we found that the diagnosed CJD patients from Beijing region had less numbers of hospital transfer and shorter interval from the disease onset to the final diagnosis than those outside of Beijing. It indicates that as the most important component, Beijing CJD surveillance network functions more actively, which supplies the special medical services not only for Beijing residents but also for patients from all of China.

Keywords:

• CJD
• surveillance
• network
• Beijing
• China

FUNDING

This work was supported by Chinese National Natural Science Foundation Grants (81301429), China Mega-Project for Infectious Disease (2011ZX10004-101, 2012ZX10004215) and SKLID Development Grant (2012SKLID102).

AUTHORS' CONTRIBUTION

Qi Shi contributed to designing and writing the paper. Xiu-Chun Zhang contributed to collecting and analyzing the data. Wei Zhou, Kang Xiao and Cao Chen contributed to analyzing the clinical data. Hai-Yan Zhang, Jing-Yi Sun, Li-Na Chen and Xiao-Mei Zhang contributed to analyzing the epidemiological data. Jun Han contributed to doing the follow-up data. Xiao-Ping Dong is the corresponding author and contributed to designing and writing the paper.